Artificial intelligence-driven decision support for patients with acute respiratory failure: a scoping review.

IF 2.8 Q2 CRITICAL CARE MEDICINE
Preeti Gupta, Alex K Pearce, Thaidan Pham, Michael Miller, Korey Brunetti, Karen Heskett, Atul Malhotra, Anoop Mayampurath, Majid Afshar
{"title":"Artificial intelligence-driven decision support for patients with acute respiratory failure: a scoping review.","authors":"Preeti Gupta, Alex K Pearce, Thaidan Pham, Michael Miller, Korey Brunetti, Karen Heskett, Atul Malhotra, Anoop Mayampurath, Majid Afshar","doi":"10.1186/s40635-025-00791-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Artificial intelligence (AI) has emerged as a promising tool for decision support in managing acute respiratory failure, yet its real-world clinical impact remains unclear. This scoping review identifies clinically validated AI-driven tools in this domain, focusing on the reporting of key evaluation quality measures that are a prerequisite for broader deployment.</p><p><strong>Eligibility criteria: </strong>Studies were included if they compared a clinical, human factors, or health systems-related outcome of an AI-driven intervention to a control group in adult patients with acute respiratory failure. Studies were excluded if they lacked a machine learning model, compared models trained on the same dataset, assessed only model performance, or evaluated models in simulated settings. A systematic literature search was conducted in PubMed, CINAHL, and EmBase, from inception until January 2025. Each abstract was independently screened by two reviewers. One reviewer extracted data and performed quality assessment, following the DECIDE-AI framework for early-stage clinical evaluation of AI-based decision support systems.</p><p><strong>Results: </strong>Of 5,987 citations, six studies met eligibility. The studies, conducted between 2012 and 2024 in Taiwan, Italy, and the U.S., included 40-2,536 patients. Four studies (67%) focused on predicting weaning from mechanical ventilation. Three (50%) of the studies demonstrated a statistically significant and clinically meaningful outcome. Studies met a median of 3.5 (IQR: 2.25-6.25) of the 17 DECIDE-AI criteria. None reported AI-related errors, malfunctions, or algorithmic fairness considerations. Only one study (17%) described user characteristics and adherence, while two (33%) assessed human-computer agreement and usability.</p><p><strong>Conclusions: </strong>Our review identified six studies evaluating AI-driven decision support tools for acute respiratory failure, with most focusing on predicting weaning from mechanical ventilation. However, methodological rigor for early clinical evaluation was inconsistent, with studies meeting few of the DECIDE-AI criteria. Notably, critical aspects such as error reporting, algorithmic fairness, and user adherence were largely unaddressed. Further high-quality assessments of reliability, usability, and real-world implementation are essential to realize the potential of these tools to transform patient care.</p>","PeriodicalId":13750,"journal":{"name":"Intensive Care Medicine Experimental","volume":"13 1","pages":"83"},"PeriodicalIF":2.8000,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12334380/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intensive Care Medicine Experimental","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40635-025-00791-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Artificial intelligence (AI) has emerged as a promising tool for decision support in managing acute respiratory failure, yet its real-world clinical impact remains unclear. This scoping review identifies clinically validated AI-driven tools in this domain, focusing on the reporting of key evaluation quality measures that are a prerequisite for broader deployment.

Eligibility criteria: Studies were included if they compared a clinical, human factors, or health systems-related outcome of an AI-driven intervention to a control group in adult patients with acute respiratory failure. Studies were excluded if they lacked a machine learning model, compared models trained on the same dataset, assessed only model performance, or evaluated models in simulated settings. A systematic literature search was conducted in PubMed, CINAHL, and EmBase, from inception until January 2025. Each abstract was independently screened by two reviewers. One reviewer extracted data and performed quality assessment, following the DECIDE-AI framework for early-stage clinical evaluation of AI-based decision support systems.

Results: Of 5,987 citations, six studies met eligibility. The studies, conducted between 2012 and 2024 in Taiwan, Italy, and the U.S., included 40-2,536 patients. Four studies (67%) focused on predicting weaning from mechanical ventilation. Three (50%) of the studies demonstrated a statistically significant and clinically meaningful outcome. Studies met a median of 3.5 (IQR: 2.25-6.25) of the 17 DECIDE-AI criteria. None reported AI-related errors, malfunctions, or algorithmic fairness considerations. Only one study (17%) described user characteristics and adherence, while two (33%) assessed human-computer agreement and usability.

Conclusions: Our review identified six studies evaluating AI-driven decision support tools for acute respiratory failure, with most focusing on predicting weaning from mechanical ventilation. However, methodological rigor for early clinical evaluation was inconsistent, with studies meeting few of the DECIDE-AI criteria. Notably, critical aspects such as error reporting, algorithmic fairness, and user adherence were largely unaddressed. Further high-quality assessments of reliability, usability, and real-world implementation are essential to realize the potential of these tools to transform patient care.

Abstract Image

Abstract Image

Abstract Image

人工智能驱动的急性呼吸衰竭患者决策支持:范围综述。
背景:人工智能(AI)已成为管理急性呼吸衰竭决策支持的有前途的工具,但其现实世界的临床影响尚不清楚。该范围审查确定了该领域临床验证的人工智能驱动工具,重点是报告关键评估质量措施,这是更广泛部署的先决条件。入选标准:如果将人工智能驱动干预的临床、人为因素或卫生系统相关结果与成年急性呼吸衰竭患者的对照组进行比较,则纳入研究。如果缺乏机器学习模型,比较在同一数据集上训练的模型,仅评估模型性能或在模拟环境中评估模型,则排除研究。在PubMed, CINAHL和EmBase中进行了系统的文献检索,从创建到2025年1月。每篇摘要由两位审稿人独立筛选。一名审稿人根据基于人工智能的决策支持系统早期临床评估的DECIDE-AI框架提取数据并进行质量评估。结果:5987次引用中,6项研究符合资格。这些研究于2012年至2024年间在台湾、意大利和美国进行,包括40- 2536名患者。四项研究(67%)关注于预测机械通气的脱机。三项(50%)的研究显示了具有统计学意义和临床意义的结果。在17项DECIDE-AI标准中,研究的中位数达到3.5 (IQR: 2.25-6.25)。没有报告人工智能相关的错误、故障或算法公平性考虑。只有一项研究(17%)描述了用户特征和依从性,而两项研究(33%)评估了人机一致性和可用性。结论:我们的综述确定了六项评估人工智能驱动的决策支持工具用于急性呼吸衰竭的研究,其中大多数研究集中在预测机械通气的脱机。然而,早期临床评估方法的严密性是不一致的,只有少数研究符合decision - ai标准。值得注意的是,错误报告、算法公平性和用户依从性等关键方面在很大程度上没有得到解决。进一步对可靠性、可用性和现实世界实施的高质量评估对于实现这些工具改变患者护理的潜力至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Intensive Care Medicine Experimental
Intensive Care Medicine Experimental CRITICAL CARE MEDICINE-
CiteScore
5.10
自引率
2.90%
发文量
48
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信